CIK 0001062822 · Non-accelerated filer<br>Smaller reporting company
LEXICON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- LXRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 760474169
- Phone
- 2818633000
- Business address
- 2445 TECHNOLOGY FOREST BLVD., SUITE 1100, THE WOODLANDS, TX, 77381
- Former names
- LEXICON PHARMACEUTICALS, INC./DE, LEXICON GENETICS INC/TX
- Open-market buys, last 90 days
- $49,999
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$49,999. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-13 | BARKER SAM L Director | Grant or award · Restricted Stock Units | +36,810 | 36,810 | ||
| 2024-05-13 | Amouyal Philippe Director | Grant or award · Stock Option (Right to Buy) | +44,906 | 44,906 | ||
| 2024-05-13 | Amouyal Philippe Director | Grant or award · Restricted Stock Units | +36,810 | 36,810 | ||
| 2024-05-10 | Artal International S.C.A. Director | Option exercise | +57,546,100 | 136,180,481 | ||
| 2024-05-10 | Artal International S.C.A. Director | Grant or award · Series A Convertible Preferred Stock | +1,150,922 | $108.50 | $124.9M | 1,150,922 |
| 2024-05-10 | Artal International S.C.A. Director | Option exercise · Series A Convertible Preferred Stock | −1,150,922 | 0 | ||
| 2024-04-28 | Swain Judith L Director | Option exercise | +8,032 | 48,364 | ||
| 2024-04-28 | Swain Judith L Director | Option exercise · Restricted Stock Units | −8,032 | 0 | ||
| 2024-04-28 | SOBECKI CHRISTOPHER J Director | Option exercise | +8,032 | 167,055 | ||
| 2024-04-28 | SOBECKI CHRISTOPHER J Director | Option exercise · Restricted Stock Units | −8,032 | 0 | ||
| 2024-04-28 | LEFKOWITZ ROBERT J MD Director | Option exercise | +8,032 | 48,364 | ||
| 2024-04-28 | LEFKOWITZ ROBERT J MD Director | Option exercise · Restricted Stock Units | −8,032 | 0 | ||
| 2024-04-28 | DEBBANE RAYMOND Director | Option exercise | +8,032 | 1,348,879 | ||
| 2024-04-28 | DEBBANE RAYMOND Director | Option exercise · Restricted Stock Units | −8,032 | 0 | ||
| 2024-04-28 | BARKER SAM L Director | Option exercise | +8,032 | 87,649 | ||
| 2024-04-28 | BARKER SAM L Director | Option exercise · Restricted Stock Units | −8,032 | 0 | ||
| 2024-04-28 | Amouyal Philippe Director | Option exercise | +8,032 | 248,364 | ||
| 2024-04-28 | Amouyal Philippe Director | Option exercise · Restricted Stock Units | −8,032 | 0 | ||
| 2024-03-13 | Artal International S.C.A. Director | Grant or award | +1,150,922 | $108.50 | $124.9M | 1,150,922 |
| 2024-02-28 | Alexander Kristen VP, Finance and Accounting | Option exercise | +2,700 | 33,050 |
Page 11 of 15 · 285 trades